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Original article
that can aid diagnosis and management (1-5). Without these 
devices, it is not possible to establish which retinal layer is 
involved.
The aim of this study was to evaluate OCT changes in pa-
tients with retinal thinning at the posterior pole.
Patients and Methods
This retrospective, cross-sectional, observational study 
followed the principles of the Declaration of Helsinki. Insti-
tutional Review Board approval was not necessary because 
of its retrospective nature. Patients were imaged using the 
Heidelberg Spectralis HRA + OCT (Heidelberg Engineering, 
Heidelberg, Germany) in SD-OCT mode, using a scan field of 
30 degrees horizontally and 15 degrees vertically and 19 to 
25 OCT horizontal sections (one section at least every 240 
μm). The Heidelberg Spectralis HRA and OCT (software ver-
sion 1.6.1.0) can be used in any one of 6 imaging modes: 
SD-OCT, fluorescein angiography, indocyanine green angiog-
raphy, autofluorescence, and red-free and infrared imaging. 
This article details use of the instrument in SD-OCT mode 
only. The Heidelberg Spectralis utilizes a broadband light 
source centered at 870 nm (i.e., no visible light “beacon”) 
to simultaneously measure multiple wavelengths, a prereq-
uisite of SD-OCT imaging. Simultaneous confocal scanning 
laser ophthalmoscopy is used to generate high-resolution 
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Introduction
Patients with a decrease in retinal thickness can present 
several vision symptoms, such as blurred vision or change in 
contrast or color sensitivity. These symptoms can be found 
in several diseases related to disturbances of the cilioretinal 
and/or choroidal flow. These flow disturbances can also cause 
localized degenerative changes associated with thinning of 
the retina. Patients are often sent for an optical coherence 
tomography (OCT) scan to better understand the reason for 
visual change.
Imaging devices can assess the retinal structure and are 
able to give useful information. Spectral-domain OCT (SD-
OCT) has the ability and the resolution to provide new infor-
mation about retinal thickness and retinal layer morphology 
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images of the retinal surface, thereby providing precise loca-
tion information of each A-scan within a cross-sectional SD-
OCT image. Spectral-domain OCT scanning generates 40,000 
A-scans/s with an axial resolution of 3.5 µm/pixel digital 
(7 µm optical) and a transverse resolution of 14 µm (6). 
Alignment software continuously tracks any eye movement 
during image acquisition and then adjusts the position of the 
A-scan on the retinal surface to ensure accurate registration 
of cross-sectional OCT images. Using eye tracking and reg-
istration technology, multiple images are obtained from a 
precise location to then be averaged and filtered to remove 
random noise from the final image. The same eye tracking/
registration technology is used to ensure that the instrument 
automatically rescans images that are influenced by blink ar-
tifacts. Similarly, follow-up images are derived from the same 
area of retina, thereby eliminating subjective placement of 
the scan by the operator.
Inclusion criteria
All the patients were referred for an OCT analysis, and 
only OCTs done from January 2011 to June 2012 were re-
viewed. The OCTs that showed an area with a retinal thick-
ness reduction at the macular region by using the Asym-
metry Analysis Map (AAM) in Heidelberg Spectralis were 
selected. In particular, when a retinal thickness difference 
was greater than 30 µm in an AAM square compared to the 
same located area of the paired eye, this difference was 
considered significant and the patient was recruited into 
the study. The presence of hemisphere asymmetry in the 
same eye and asymmetry between the paired eyes were 
calculated and used for the analysis. Retinal thickness was 
measured in 3 different retinal areas (squares): (1) the area 
(square) involved by the pathology (IA); (2) the specular 
area (square) in the opposite hemifield (SA); and (3) the cor-
responding IA in the contralateral eye (CIA) (area used to 
recruit the patients) (Fig. 1).
Exclusion criteria
Patients with age-related macular degeneration, diabetic 
retinopathy, and/or vitreoretinal pathologies (i.e., macular 
hole and lamellar macular hole) were not included in the 
study, because these pathologies could create a significant 
retinal anatomical layer change. Patients with more than one 
ocular pathology (i.e., glaucoma and branch retinal artery oc-
clusion [BRAO]) were not included in the study. Only one eye 
per patient was selected.
In this study, to find patients with retinal thinning by OCT, 
all OCT scans were reviewed, and only those with retinal thin-
ning were selected. Then all the OCT scans were subjectively 
analyzed by 2 users just observing the Spectralis screen to dis-
tinguish which retinal layers were involved. The retinal thick-
ness reduction was classified as internal when the ganglion 
cell complex (i.e., retinal nerve fiber, ganglion, inner plexi-
form, and nuclear layers) was involved, or external when the 
external layer (i.e., outer nuclear, outer plexiform, neuroepi-
thelium, or pigment epithelium layers) was involved.
Statistical analysis
The data were analyzed by descriptive analysis and when 
the distribution of the data was normal, t test and Pearson r  
coefficient were used, while when the distribution of the 
data was non-normal, Mann-Whitney test and Spearman 
coefficient were used. Kruskal-Wallis test was used to com-
pare the different subgroups. A p value <0.05 was considered 
significant.
Fig. 1 - Printout of the Asymmetry 
Analysis Map: the user found the 
involved area and then the thin-
nest area was considered, together 
with the specular area and the cor-
responding area, as described in the 
text.
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results
A total of 648 patient files were reviewed and 67 eyes 
of 67 patients were selected. Table I lists the details of the 
included patients. The thickness of the IA was 235.54 ± 39.95 
µm (mean ± standard deviation), while it was 269.84 ± 36.16 
µm and 293.81 ± 37.52 µm for SA and CIA, respectively 
(Tabs. II and III). A significant (p<0.001) difference was found 
between IA and both SA and CIA (Tab. II).
The retinal morphology was analyzed observing the OCT 
scans on the screen and 2 different subgroups of patients 
were found based on retinal involvement: a reduction of the 
inner layers or a reduction of the outer retinal layer. When 
eyes with a reduction of the inner layers were compared 
to those with a reduction of the outer retinal layer, no sig-
nificant difference was found for IA and SA, except for CIA 
(Tab. IV). Then the diagnosis of each patient was considered 
and the group was divided into subgroups based on the di-
agnosis (Tab. III). No significant difference in retinal thickness 
was found among the diagnosis groups, but when the diag-
nosis was associated with retinal layer involvement, a signifi-
cant difference was found among different pathologies. In 
particular, in all the optic neuropathy patients (primary open-
angle glaucoma and anterior ischemic optic  neuropathy) and 
TABLe I - Descriptive analysis of the 6 subgroups






BRAO 72 (0.3) 2 I
rCSC 44.3 (6.9) 8 E
POAG 71 (12.1) 19 I
AION 71.7 (12.2) 15 I
Post PDT for CSC 73.3 (10) 3 E
CSE 64.3 (10.5) 20 E
AION = anterior ischemic optic neuropathy; BRAO = branch retinal artery oc-
clusion; CSC = central serous chorioretinopathy; CSE = chronic serous epithe-
liopathy; E = external retinal layer involved; I = internal retinal layers involved; 
POAG = primary open angle glaucoma; PDT = photodynamic therapy; rCSC = 
resolved central serous chorioretinopathy.
TABLe II - Descriptive analysis of the entire cohort of patients




Mean 66.29 235.54 269.84 34.47 293.81 58.00
SD 13.42 39.95 36.16 29.69 37.52 25.83
p Value IA vs SA 
<0.001
CIA vs IA 
<0.001
CIA = the corresponding area involved by the pathology in the contralateral 
eye; IA = the area involved by the pathology; SA = the specular area in the 
opposite hemifield.
TABLe III - Comparison among the different diagnosis subgroups


































































AION = anterior ischemic optic neuropathy; BRAO = branch retinal artery oc-
clusion; CIA = the corresponding area involved by the pathology in the con-
tralateral eye; CSE = central serous epitheliopathy; IA = the area involved by 
the pathology; PDT = photodynamic therapy; POAG = primary open-angle 
glaucoma; rCSC = resolved central serous chorioretinopathy; SA = the specu-
lar area in the opposite hemifield.
TABLe IV -  Comparison between patients with internal retinal lay-
ers involved and those with external retinal layer in-
volved





 Mean 238.23 274.29 36.06 307.29 67.45
 SD 46.13 39.66 33.43 40.36 27.71
p Value 0.475 0.324 0.282 0.008 <0.001
Internal layer
 Mean 238.81 270.42 31.94 285.23 47.23
 SD 28.86 29.45 24.72 31.31 19.03
CIA = the corresponding area involved by the pathology in the contralateral 
eye; IA = the area involved by the pathology; SA = the specular area in the 
opposite hemifield.
in those with BRAO, a reduction of the ganglion cell complex 
was observed (Figs 2-4) while in patients with resolved cen-
tral serous chorioretinopathy, post photodynamic therapy, 
and chronic serous epitheliopathy, a reduction of the outer 
retinal layer was observed (Figs. 5-7).
Discussion
Optical coherence tomography in clinical practice has im-
proved the imaging of the retina with better morphologic and 
morphometric information. Previous studies have shown that 
SD-OCT reveals retinal pathology that was not visible using 
OCT in retinal diseases4 
© 2015 Wichtig Publishing
Fig. 2 - Patient with left anterior ischemic optic neuropathy: reduc-
tion of ganglion cell complex (retinal nerve fiber layer and ganglion 
cell layer).
Fig. 3 - Patient with right branch retinal artery occlusion: reduction 
of inner retinal layers up to the outer plexiform layer.
Fig. 4 - Patient with right primary open-angle glaucoma: reduction 
of ganglion cell complex.
Fig. 5 - Patient with right central serous chorioretinopathy: reduc-
tion of outer nuclear layer and neuroepithelium/retinal pigment 
epithelium dystrophy.
Fig. 6 - Patient with left chronic serous epitheliopathy: reduction of 
neuroepithelium and outer nuclear and plexiform layers.
Fig. 7 - Patient after photodynamic therapy in right eye: reduction 
of outer nuclear layer.
Iester et al  5
© 2015 Wichtig Publishing  
time-domain OCT, such as intraretinal cysts and subretinal 
fluid (7). Spectral-domain OCT also adds information to com-
plete the clinical picture, providing more detailed resolution 
of retinal changes, such as full-thickness folds of the retinal 
pigment epithelium (RPE) and intraretinal edema in case of 
RPE detachment, branch retinal vein occlusion, toxoplasma 
chorioretinitis, and polypoidal choroidal vasculopathy (8).
In this study, high OCT resolution was used to better un-
derstand retinal layers involvement in different diseases (3, 
5). From morphologic observation of the scans, a thinning 
of the ganglion cell complex layers and the inner plexiform 
layer was found in patients with ganglion cell complex dis-
eases such as ONH diseases as well as in patients with retinal 
artery disease. On the other hand, in patients with retinal pa-
thologies in which the choroidal flow was involved, an outer 
nuclear layer, outer plexiform layer, and/or neuroepithelium 
thinning was observed. Ghazi et al (9) found that a loss of the 
inner retinal layer could differentiate postacute retinal artery 
occlusion from nonacute optic neuropathy, confirming part 
of our results.
The ability of SD-OCT to clearly and objectively elucidate 
subtle morphologic changes within the retinal layers provides 
information that could be useful to better explain patients’ 
symptoms. The ability to evaluate each retinal layer permits 
better assessment of the retinal reduction and understanding 
of the location of the damage in the vision pathway. How-
ever, in this study, no difference in retinal thickness was found 
among patients with different diseases; we could not perform 
an automatic segmentation analysis, and we assessed the ret-
inal layers all together.
A significant difference was found between the area with 
the disease (IA) and the specular area across the hemi-me-
ridian (SA) and the corresponding area in the other eye (CIA), 
suggesting that all these patients had retinal thinning due to 
their diseases.
When the subgroup with inner retinal thinning was com-
pared to that with outer retinal thinning, no difference was 
found for IA and SA, but for CIA a significant difference was 
found between the 2 subgroups. These data could be ex-
plained because ONH disease and artery disease are mainly 
systemic diseases and both eyes could be involved in different 
ways. Indeed, the retinal thickness was thinner in the sub-
group with inner thinning. Furthermore, in the post photody-
namic therapy subgroup, all patients had a retinal thinning of 
the outer layers, where the treatment was focused.
A possible bias of this study could be that in healthy sub-
jects the retinal thickness is similar in the IA, SA, and CA; 
however, we selected areas, and not points, that had a retinal 
reduction in the AAM. The utility of the areas could guarantee 
a good clinical judgment even if the measurement was less 
accurate for the noise in the measurement. Other possible 
biases could be the design of the study (cross-sectional), the 
selection of patients (inclusion and exclusion criteria), and 
the number of included patients, but we tried to avoid any 
clinical noise among the selected patients by using strict in-
clusion/exclusion criteria.
We selected patients on the basis of the retinal thinning and 
not the disease, because from the clinical point of view, patients 
are sent for an OCT scan without any diagnosis. This could be 
a bias for the study because the sample selected could be too 
heterogeneous, but on the other hand, these data could help 
the OCT user to read the scan and make the diagnosis. Besides 
the ability of SD-OCT to elucidate clearly and objectively subtle 
morphologic changes within the retinal layers, it provides infor-
mation that could be used to confirm diagnoses with greater 
confidence. Because this imaging technology offers a previously 
unattainable resolution of retinal morphology, a more accurate 
intraretinal diagnosis could be done in the future.
In conclusion, we showed that if there is retinal thinning 
by OCT, it is important to evaluate which retinal layer is in-
volved: a reduction of the inner layers was related to disease 
in which ciliary or retinal arterial vessel flow was involved, 
while a reduction of the outer retinal layer was related to pa-
thologies related to choroidal flow diseases. The possibility 
to use a retinal segmentation program to assess objectively 
morphologic changes within the retinal layers that are not 
visible using conventional clinical techniques could be useful 
in clinical practice. (Figs. 4-7).
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